Related Experiment Video
Updated: Jun 13, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in
Harald Sourij1, Christoph H Saely, Fabian Schmid
1Metabolism and Vascular Biology Research Group, Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Insights
Post-challenge hyperglycaemia in coronary patients significantly increases the risk of future macrovascular events. An oral glucose tolerance test (oGTT) identifies these high-risk individuals with an unfavorable prognosis.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Post-challenge hyperglycaemia is prevalent in patients with coronary artery disease.
- The association between post-challenge hyperglycaemia and macrovascular events in this population remains unclear.
Purpose of the Study:
- To investigate the risk of future macrovascular events in coronary patients with post-challenge hyperglycaemia.
Main Methods:
- 1040 patients undergoing coronary angiography were enrolled.
- Oral glucose tolerance tests (oGTT) were performed in patients without pre-existing diabetes.
- Macrovascular events and mortality were prospectively recorded over a 3.8-year follow-up.
Main Results:
- Patients with post-challenge hyperglycaemia (280) and conventional diabetes (366) had significantly higher macrovascular event rates than those with normal glucose tolerance (394).
- Adjusted hazard ratios for macrovascular events were 1.46 for post-challenge hyperglycaemia and 1.73 for conventional diabetes.
- Post-challenge hyperglycaemia indicates a particularly unfavorable prognosis in stable coronary artery disease patients.
Conclusions:
- Post-challenge hyperglycaemia is linked to increased future macrovascular events in patients evaluated for coronary artery disease.
- oGTTs identify high-risk individuals with poor prognosis in this population.
Aims:
The prevalence of post-challenge hyperglycaemia in coronary patients is high. Until now, it is unclear whether post-challenge hyperglycaemia is associated with an increased risk for future macrovascular events in this clinically important patient population.
Methods And Results:
We enrolled 1040 patients undergoing coronary angiography for the evaluation of suspected or established coronary artery disease. In patients without previously established diabetes mellitus, an oral glucose tolerance test (oGTT) was performed. Prospectively, mortality and macrovascular events were recorded over a mean follow-up period of 3.8 years. From our patients, 394 had normal glucose tolerance (NGT), 280 post-challenge hyperglycaemia (this subgroup includes both impaired glucose tolerance and post-challenge diabetes) and 366 had conventional diabetes. The incidence of macrovascular events was significantly higher in patients with post-challenge hyperglycaemia as well as in patients with conventional diabetes than in subjects with NGT (23.6 and 29.5% vs. 18.5%; P = 0.013 and P < 0.001, respectively). Adjusted hazard ratios were 1.46 (95% CI 1.03-2.07, P = 0.033) for patients with post-challenge hyperglycaemia and 1.73 (1.25-2.37, P = 0.001) for patients with conventional diabetes.
Conclusion:
Post-challenge hyperglycaemia is associated with future macrovascular events in patients undergoing coronary angiography for the evaluation of stable coronary artery disease (CAD). Oral glucose tolerance tests in this high-risk population thus identify patients with a particularly unfavourable prognosis.
Related Concept Videos
Hyperglycemia
Complications of Diabetes Mellitus
Diabetic Retinopathy
Coronary Artery Disease I: Introduction
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational